This study aimed to develop a predictive tool for unplanned cesarean delivery (CD) in nulliparous women using prenatal maternal and fetal characteristics. Over 2,200 nulliparous women were prospectively studied across seven Irish hospitals. Multivariate analysis identified that maternal age, BMI, height, fetal abdominal circumference, and head circumference can predict CD risk. A nomogram was developed and showed good predictive ability, with an AUC of 0.69. The tool may help counsel women on their chances of a vaginal delivery versus an elective CD.
Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations
N. O'Gorman, D. Wright, L. C. Poon, D. L. Rolnik, A. Syngelaki, M. de Alvarado, I. F. Carbone, V. Dutemeyer, M. Fiolna, A. Frick, N. Karagiotis, S. Mastrodima, C. de Paco Matallana, G. Papaioannou, A. Pazos, W. Plasencia, K. H. Nicolaides
Volume 49, Issue 6, Pages 756–760
Slides prepared by Dr Fiona Brownfoot (UOG Editor-for-Trainees)
Read the free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.17455/full
Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leimyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis
C. A. Bittencourt, R. dos Santos Simões, W.M. Bernardo, L. F. P. Fuchs,J. M. Soares Júnior, A.R. Pastore and E.C. Baracat
Volume 50, Issue 1, Date: July Pages: 32–39
Slides prepared by Dr Joel Naftalin (UOG Editor-for-Trainees)
Read the free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.17352/full
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10–11 weeks’ gestation and the combined test at 11–13 weeks
M. S. Quezada, M. M. Gil, C. Francisco, G. Oròsz and K. H. Nicolaides
Volume 45, Issue 1, pages 36–41, January 2015
http://onlinelibrary.wiley.com/doi/10.1002/uog.14664/full
Longitudinal hemodynamics in acute phase of treatment with labetalol in hypertensive pregnant women to predict need for vasodilatory therapy
D. Stott, M. Bolten, D. Paraschiv, I. Papastefanou, J.B. Chambers and N.A. Kametas
Volume 49, Issue 1, Date: January (pages 85–94)
Read the free-access article here: http://onlinelibrary.wiley.com/doi/10.1002/uog.17335/full
Serial hemodynamic monitoring to guide treatment of maternal hypertension leads to reduction in severe hypertension
D. Stott, I. Papastefanou, D. Paraschiv, K. Clark and N.A. Kametas
Volume 49, Issue 1, Date: January (pages 95–103)
Read the free-access article here: http://onlinelibrary.wiley.com/doi/10.1002/uog.17341/full
Slides prepared by Dr Katherine Goetzinger (UOG Editor for Trainees)
Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis–fundus height
M. Griffin, P. T. Seed, L. Webster, J. Myers, L. MacKillop, N. Simpson, D. Anumba, A. Khalil, M. Denbow, A. Sau, K. Hinshaw, P. von Dadelszen, S. Benton, J. Girling, C. W. G. Redman, L. C. Chappell and A. H. Shennan
Volume 46, Issue 2, pages 182–190, August 2015
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14860/full
Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: systematic review and meta-analysis
M. Grande, F. A. R. Jansen, Y. J. Blumenfeld, A. Fisher, A. O. Odibo, M. C. Haak and A. Borrell
Volume 46, Issue 6, Date: December, pages 650–658
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14880/abstract
Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data
V. Berghella, M. Palacio, A. Ness, Z. Alfirevic, K. H. Nicolaides and G. Saccone
Volume 49, Issue 3, Date: March (pages 322–329)
Slides prepared by Dr Shireen Meher (UOG Editors-for-Trainees)
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.17388/full
Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations
N. O'Gorman, D. Wright, L. C. Poon, D. L. Rolnik, A. Syngelaki, M. de Alvarado, I. F. Carbone, V. Dutemeyer, M. Fiolna, A. Frick, N. Karagiotis, S. Mastrodima, C. de Paco Matallana, G. Papaioannou, A. Pazos, W. Plasencia, K. H. Nicolaides
Volume 49, Issue 6, Pages 756–760
Slides prepared by Dr Fiona Brownfoot (UOG Editor-for-Trainees)
Read the free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.17455/full
Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leimyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis
C. A. Bittencourt, R. dos Santos Simões, W.M. Bernardo, L. F. P. Fuchs,J. M. Soares Júnior, A.R. Pastore and E.C. Baracat
Volume 50, Issue 1, Date: July Pages: 32–39
Slides prepared by Dr Joel Naftalin (UOG Editor-for-Trainees)
Read the free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.17352/full
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10–11 weeks’ gestation and the combined test at 11–13 weeks
M. S. Quezada, M. M. Gil, C. Francisco, G. Oròsz and K. H. Nicolaides
Volume 45, Issue 1, pages 36–41, January 2015
http://onlinelibrary.wiley.com/doi/10.1002/uog.14664/full
Longitudinal hemodynamics in acute phase of treatment with labetalol in hypertensive pregnant women to predict need for vasodilatory therapy
D. Stott, M. Bolten, D. Paraschiv, I. Papastefanou, J.B. Chambers and N.A. Kametas
Volume 49, Issue 1, Date: January (pages 85–94)
Read the free-access article here: http://onlinelibrary.wiley.com/doi/10.1002/uog.17335/full
Serial hemodynamic monitoring to guide treatment of maternal hypertension leads to reduction in severe hypertension
D. Stott, I. Papastefanou, D. Paraschiv, K. Clark and N.A. Kametas
Volume 49, Issue 1, Date: January (pages 95–103)
Read the free-access article here: http://onlinelibrary.wiley.com/doi/10.1002/uog.17341/full
Slides prepared by Dr Katherine Goetzinger (UOG Editor for Trainees)
Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis–fundus height
M. Griffin, P. T. Seed, L. Webster, J. Myers, L. MacKillop, N. Simpson, D. Anumba, A. Khalil, M. Denbow, A. Sau, K. Hinshaw, P. von Dadelszen, S. Benton, J. Girling, C. W. G. Redman, L. C. Chappell and A. H. Shennan
Volume 46, Issue 2, pages 182–190, August 2015
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14860/full
Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: systematic review and meta-analysis
M. Grande, F. A. R. Jansen, Y. J. Blumenfeld, A. Fisher, A. O. Odibo, M. C. Haak and A. Borrell
Volume 46, Issue 6, Date: December, pages 650–658
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14880/abstract
Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data
V. Berghella, M. Palacio, A. Ness, Z. Alfirevic, K. H. Nicolaides and G. Saccone
Volume 49, Issue 3, Date: March (pages 322–329)
Slides prepared by Dr Shireen Meher (UOG Editors-for-Trainees)
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.17388/full
Systematic review of accuracy of ultrasound in the diagnosis of vasa previa
L. Ruiter, N. Kok, J. Limpens, J.B. Derks, I.M. de Graaf, B.W.J. Mol and E. Pajkrt
Volume 45, Issue 5, pages 516–522, May 2015
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14752/full
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis
M. M. Gil, M. S. Quezada, R. Revello, R. Akolekar and K. H. Nicolaides
Volume 45, Issue 3, pages 249–266, March 2015
http://onlinelibrary.wiley.com/doi/10.1002/uog.14791/full
UOG Journal Club: Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study
C. A. Walsh, B. Doyle, J. Quigley, F. M. McAuliffe, J. Fitzgerald, R. Mahony, S. Higgins, S. Carroll and P. McParland
Volume 44, Issue 6, pages 669–673, December 2014
http://onlinelibrary.wiley.com/doi/10.1002/uog.13383/abstract
Increased nuchal translucency thickness and risk of neurodevelopmental disorders
S. G. Hellmuth, L. H. Pedersen, C. B. Miltoft, O. B. Petersen, S. Kjærgaard, C. Ekelund, A. Tabor
Volume 49, Issue 5; Date: May (pages 592–598)
Slides prepared by Dr Maddalena Morlando (UOG Editors-for-Trainees)
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.15961/full
The Journal club for May features 2 papers. The first is a study on Angiogenic Factors vs. Doppler Surveillance in the Prediction of ddverse outcomes in late pregnancy SGA fetuses. The second studies the uterine artery Doppler and sFlt-1/PlGF ratio, discussing its value in diagnosis of early-onset pre-eclampsia.
Angiogenic Factors vs. Doppler Surveillance in the Prediction of Adverse Outcome Among Late-Pregnancy Small-for-Gestational-Age Fetuses
S.M. Lobmaier, F. Figueras, I, Mercade, M. Perello, A. Peguero, F. Crovetto, J.U. Ortiz, F. Crispi and E. Gratacos
Volume 43, Issue 5, Date: May 2014, pages 533-540
Uterine Artery Doppler and sFlt-1/PlGF Ratio: Prognostic Value in Early-Onset Pre-Eclampsia
P.I. Gomez-Arriaga, I. Herraiz, E.A. Lopez-Jiminez, D. Escribano, B. Denk and A. Galindo
Volume 43, Issue 5, Date: May 2014, pages 525-532
Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure
M. Teixidor Vinas, A. M. Belli, S. Arulkumaran and E. Chandraharan
Volume 46, Issue 3, Date: September, pages 350–355
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14728/full
Effects of intrauterine retention and postmortem interval on body weight following intrauterine death: implications for assessment of fetal growth restriction at autopsy
J Man, JC Hutchinson, M Ashworth, AE Heazell, S Levine and NJ Sebire
Volume 47, Issue 11; Date: November, pages 574–578
Read the free-access article here: http://onlinelibrary.wiley.com/doi/10.1002/uog.16018/full
Organ weights and ratios for postmortem identification of fetal growth restriction: utility and confounding factors
J Man, JC Hutchinson, M Ashworth, I Jeffrey, AE Heazell, and NJ Sebire
Volume 48, Issue 5; Date: November, pages 585–590
Read the free-access article here: http://onlinelibrary.wiley.com/doi/10.1002/uog.16017/full
Estimation of Fetal Size and Weight using Various Formulasijtsrd
Birth weight is an important factor in delivery management. Antenatal ultrasound has turned out to be one of the clinicians most vital devices for surveying fetal age, growth and prosperity. Contrasted Physical examination of the pregnant uterus is the most precise strategy for evaluating fetal size and growth along with the utilization of ultrasound imaging and estimating of the different fetal parameters. Objective To evaluates the antenatal assessments of fetal weight in pregnancies by using Johnsons formula, Hadlocks formula and Ultrasonography. Comparison of these different methods with the actual birth weight of these babies after delivered. Material and methods Two hundred singleton term pregnancies within 48 hours were randomly selected to participate in this prospective cohort study. Variables included such as abdominal circumference, Biparietal diameter, and Femur length. Parameters to obtain estimated fetal weight Results The mean birth weight of Hadlock formula is closest to the mean of actual birth weight. In the study population, more primigravida delivered babies with very low birth weight and more multigravida delivered babies of birth weight 3500 gms. Johnsons and ultrasound Hadlocks formula had a marked tendency to overestimate the fetal weight. Error was within 350 Gms in 84.7 , 70.8 and 84 of cases by Dares, Johnsons and ultrasound Hadlocks formula. Dr. Pushpamala Ramaiah | Dr. Lamiaa Ahmed Elsayed | Dr. Grace Lindsey | Dr. Ayman Johargy ""Estimation of Fetal Size and Weight using Various Formulas"" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-3 , April 2019, URL: https://www.ijtsrd.com/papers/ijtsrd23231.pdf
Paper URL: https://www.ijtsrd.com/medicine/nursing/23231/estimation-of-fetal-size-and-weight-using-various-formulas/dr-pushpamala-ramaiah
Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial): a multicenter, open‐label, randomized controlled trial
S Kehl, A Schelkle, A Thomas, A Puhl, K Meqdad, B Tuschy, S Berlit, C Weiss, C Bayer, J Heimrich, U Dammer, E Raabe, M Winkler, F Faschingbauer, MW Beckmann, M Sutterlin
Volume 47, Issue 6, Date: June (pages 674–679)
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14924/full
Poor neonatal acid–base status in term fetuses with low cerebroplacental ratio
J. Morales-Roselló, A. Khalil, M. Morlando, A. Bhide, A. Papageorghiou and B. Thilaganathan
Volume 45, Issue 2, Date: February (pages 156–161)
http://onlinelibrary.wiley.com/doi/10.1002/uog.14647/abstract
Human fetal growth is constrained below optimal for perinatal survival
B. Vasak, S.V. Koenen, M.P.H. Koster, C.W.P.M. Hukkelhoven, A. Franx, M.A. Hanson and G.H.A. Visser
Volume 45, Issue 2, Date: February (pages 162–167)
http://onlinelibrary.wiley.com/doi/10.1002/uog.14644/abstract
UOG Journal Club: October 2013
Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
C. Lees, N. Marlow, B. Arabin, C. M. Bilardo, C. Brezinka, J. B. Derks, J. Duvekot, T. Frusca, A. Diemert, E. Ferrazzi, W. Ganzevoort, K. Hecher, P. Martinelli, E. Ostermayer, A. T. Papageorghiou, D. Schlembach, K. T. M. Schneider, B. Thilaganathan, T. Todros, A. van Wassenaer-Leemhuis, A. Valcamonico, G. H. A. Visser and H. Wolf
Link to the free-access article:
http://onlinelibrary.wiley.com/doi/10.1002/uog.13190/abstract
Perinatal and long-term outcomes in fetuses diagnosed with isolated unilateral ventriculomegaly: systemic review and meta-analysis
C. Scala, A. Familiari, A. Pinas, A.T. Papageorghiou, A. Bhide, B. Thilaganathan, A. Khalil
Volume 49, Issue 4, Date: April (pages 450–459)
Slides prepared by Dr Yael Raz (UOG Editor-for-Trainees)
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.15943/full
Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test
M. M. Gil, R. Revello, L. C. Poon, R. Akolekar and K. H. Nicolaides
Volume 47, Issue 1; pages 45–52
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.15783/full
GnRH agonist during luteal phase in women undergoing assisted reproductive techniques: systematic review and meta-analysis of randomized controlled trials
W. P. Martins, R. A. Ferriani, P. A. Navarro and C. O. Nastri
Volume 47, Issue 2; pages 144–151
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14874/full
Ultrasound screening for fetal growth restriction at 36 vs 32 weeks' gestation: a randomized trial (ROUTE)
E. Roma, A. Arnau, R. Berdala, C. Bergos, J. Montesinos and F. Figueras
Volume 46, Issue 4, pages 391–397
View the free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14915/full
UOG Journal Club: December 2013
Relationship of isolated single umbilical artery to fetal growth, aneuploidy and perinatal mortality: systematic review with meta-analysis
B.J. Voskamp, H. Fleurke-Rozema, K.O. Rengerink, R.J.M. Snijders, C.M. Bilardo, B.W.J. Mol and E. Pajkrt
Link to free access article:
http://onlinelibrary.wiley.com/doi/10.1002/uog.12541/abstract
Agreement of two-dimensional and three-dimensional transvaginal ultrasound with magnetic resonance imaging in assessment of parametrial infiltration in cervical cancer
V. Chiappa, A. Di Legge, A.L. Valentini, B. Gui, M. Micco, M. Ludovisi, C. Giansiracusa, A.C. Testa and L. Valentin
Volume 45, Issue 4, pages 459–469, April 2015
http://onlinelibrary.wiley.com/doi/10.1002/uog.14637/abstract
Placental Elastography in Intrauterine Growth Restriction: A Case–control Studyasclepiuspdfs
Background: Intrauterine growth restriction (IUGR) is related to poor fetal outcome. Though, various tools are available for evaluation of IUGR they are notreliable inearly diagnosis of IUGR. Shear wave elastography (SWE) can be used to study the change in mechanical properties of various disease which can be a potential technique for early diagnosis of IUGR. Objective: The objective of the study was to compare the differences in SWE values of placentas between IUGR and normal pregnancies. Methodology: Normal second- and third-trimester pregnancies and IUGR pregnancies between 24 and 42 weeks period of gestation (POG), meeting the inclusion criteria were matched for age group and POG. SWE of placenta was performed in supine position during quiet respiration. The SWE of placenta was measured by placing the region of interest in relatively homogeneous area. The placental elasticity values obtained in pregnancies complicated by IUGR were compared with that of normal controls. Umbilical artery (UA) and fetal middle cerebral artery (MCA) Doppler findings were correlated with placental elasticity value of IUGR pregnancies.
Systematic review of accuracy of ultrasound in the diagnosis of vasa previa
L. Ruiter, N. Kok, J. Limpens, J.B. Derks, I.M. de Graaf, B.W.J. Mol and E. Pajkrt
Volume 45, Issue 5, pages 516–522, May 2015
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14752/full
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis
M. M. Gil, M. S. Quezada, R. Revello, R. Akolekar and K. H. Nicolaides
Volume 45, Issue 3, pages 249–266, March 2015
http://onlinelibrary.wiley.com/doi/10.1002/uog.14791/full
UOG Journal Club: Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study
C. A. Walsh, B. Doyle, J. Quigley, F. M. McAuliffe, J. Fitzgerald, R. Mahony, S. Higgins, S. Carroll and P. McParland
Volume 44, Issue 6, pages 669–673, December 2014
http://onlinelibrary.wiley.com/doi/10.1002/uog.13383/abstract
Increased nuchal translucency thickness and risk of neurodevelopmental disorders
S. G. Hellmuth, L. H. Pedersen, C. B. Miltoft, O. B. Petersen, S. Kjærgaard, C. Ekelund, A. Tabor
Volume 49, Issue 5; Date: May (pages 592–598)
Slides prepared by Dr Maddalena Morlando (UOG Editors-for-Trainees)
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.15961/full
The Journal club for May features 2 papers. The first is a study on Angiogenic Factors vs. Doppler Surveillance in the Prediction of ddverse outcomes in late pregnancy SGA fetuses. The second studies the uterine artery Doppler and sFlt-1/PlGF ratio, discussing its value in diagnosis of early-onset pre-eclampsia.
Angiogenic Factors vs. Doppler Surveillance in the Prediction of Adverse Outcome Among Late-Pregnancy Small-for-Gestational-Age Fetuses
S.M. Lobmaier, F. Figueras, I, Mercade, M. Perello, A. Peguero, F. Crovetto, J.U. Ortiz, F. Crispi and E. Gratacos
Volume 43, Issue 5, Date: May 2014, pages 533-540
Uterine Artery Doppler and sFlt-1/PlGF Ratio: Prognostic Value in Early-Onset Pre-Eclampsia
P.I. Gomez-Arriaga, I. Herraiz, E.A. Lopez-Jiminez, D. Escribano, B. Denk and A. Galindo
Volume 43, Issue 5, Date: May 2014, pages 525-532
Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure
M. Teixidor Vinas, A. M. Belli, S. Arulkumaran and E. Chandraharan
Volume 46, Issue 3, Date: September, pages 350–355
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14728/full
Effects of intrauterine retention and postmortem interval on body weight following intrauterine death: implications for assessment of fetal growth restriction at autopsy
J Man, JC Hutchinson, M Ashworth, AE Heazell, S Levine and NJ Sebire
Volume 47, Issue 11; Date: November, pages 574–578
Read the free-access article here: http://onlinelibrary.wiley.com/doi/10.1002/uog.16018/full
Organ weights and ratios for postmortem identification of fetal growth restriction: utility and confounding factors
J Man, JC Hutchinson, M Ashworth, I Jeffrey, AE Heazell, and NJ Sebire
Volume 48, Issue 5; Date: November, pages 585–590
Read the free-access article here: http://onlinelibrary.wiley.com/doi/10.1002/uog.16017/full
Estimation of Fetal Size and Weight using Various Formulasijtsrd
Birth weight is an important factor in delivery management. Antenatal ultrasound has turned out to be one of the clinicians most vital devices for surveying fetal age, growth and prosperity. Contrasted Physical examination of the pregnant uterus is the most precise strategy for evaluating fetal size and growth along with the utilization of ultrasound imaging and estimating of the different fetal parameters. Objective To evaluates the antenatal assessments of fetal weight in pregnancies by using Johnsons formula, Hadlocks formula and Ultrasonography. Comparison of these different methods with the actual birth weight of these babies after delivered. Material and methods Two hundred singleton term pregnancies within 48 hours were randomly selected to participate in this prospective cohort study. Variables included such as abdominal circumference, Biparietal diameter, and Femur length. Parameters to obtain estimated fetal weight Results The mean birth weight of Hadlock formula is closest to the mean of actual birth weight. In the study population, more primigravida delivered babies with very low birth weight and more multigravida delivered babies of birth weight 3500 gms. Johnsons and ultrasound Hadlocks formula had a marked tendency to overestimate the fetal weight. Error was within 350 Gms in 84.7 , 70.8 and 84 of cases by Dares, Johnsons and ultrasound Hadlocks formula. Dr. Pushpamala Ramaiah | Dr. Lamiaa Ahmed Elsayed | Dr. Grace Lindsey | Dr. Ayman Johargy ""Estimation of Fetal Size and Weight using Various Formulas"" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-3 , April 2019, URL: https://www.ijtsrd.com/papers/ijtsrd23231.pdf
Paper URL: https://www.ijtsrd.com/medicine/nursing/23231/estimation-of-fetal-size-and-weight-using-various-formulas/dr-pushpamala-ramaiah
Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial): a multicenter, open‐label, randomized controlled trial
S Kehl, A Schelkle, A Thomas, A Puhl, K Meqdad, B Tuschy, S Berlit, C Weiss, C Bayer, J Heimrich, U Dammer, E Raabe, M Winkler, F Faschingbauer, MW Beckmann, M Sutterlin
Volume 47, Issue 6, Date: June (pages 674–679)
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14924/full
Poor neonatal acid–base status in term fetuses with low cerebroplacental ratio
J. Morales-Roselló, A. Khalil, M. Morlando, A. Bhide, A. Papageorghiou and B. Thilaganathan
Volume 45, Issue 2, Date: February (pages 156–161)
http://onlinelibrary.wiley.com/doi/10.1002/uog.14647/abstract
Human fetal growth is constrained below optimal for perinatal survival
B. Vasak, S.V. Koenen, M.P.H. Koster, C.W.P.M. Hukkelhoven, A. Franx, M.A. Hanson and G.H.A. Visser
Volume 45, Issue 2, Date: February (pages 162–167)
http://onlinelibrary.wiley.com/doi/10.1002/uog.14644/abstract
UOG Journal Club: October 2013
Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
C. Lees, N. Marlow, B. Arabin, C. M. Bilardo, C. Brezinka, J. B. Derks, J. Duvekot, T. Frusca, A. Diemert, E. Ferrazzi, W. Ganzevoort, K. Hecher, P. Martinelli, E. Ostermayer, A. T. Papageorghiou, D. Schlembach, K. T. M. Schneider, B. Thilaganathan, T. Todros, A. van Wassenaer-Leemhuis, A. Valcamonico, G. H. A. Visser and H. Wolf
Link to the free-access article:
http://onlinelibrary.wiley.com/doi/10.1002/uog.13190/abstract
Perinatal and long-term outcomes in fetuses diagnosed with isolated unilateral ventriculomegaly: systemic review and meta-analysis
C. Scala, A. Familiari, A. Pinas, A.T. Papageorghiou, A. Bhide, B. Thilaganathan, A. Khalil
Volume 49, Issue 4, Date: April (pages 450–459)
Slides prepared by Dr Yael Raz (UOG Editor-for-Trainees)
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.15943/full
Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test
M. M. Gil, R. Revello, L. C. Poon, R. Akolekar and K. H. Nicolaides
Volume 47, Issue 1; pages 45–52
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.15783/full
GnRH agonist during luteal phase in women undergoing assisted reproductive techniques: systematic review and meta-analysis of randomized controlled trials
W. P. Martins, R. A. Ferriani, P. A. Navarro and C. O. Nastri
Volume 47, Issue 2; pages 144–151
Link to free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14874/full
Ultrasound screening for fetal growth restriction at 36 vs 32 weeks' gestation: a randomized trial (ROUTE)
E. Roma, A. Arnau, R. Berdala, C. Bergos, J. Montesinos and F. Figueras
Volume 46, Issue 4, pages 391–397
View the free-access article: http://onlinelibrary.wiley.com/doi/10.1002/uog.14915/full
UOG Journal Club: December 2013
Relationship of isolated single umbilical artery to fetal growth, aneuploidy and perinatal mortality: systematic review with meta-analysis
B.J. Voskamp, H. Fleurke-Rozema, K.O. Rengerink, R.J.M. Snijders, C.M. Bilardo, B.W.J. Mol and E. Pajkrt
Link to free access article:
http://onlinelibrary.wiley.com/doi/10.1002/uog.12541/abstract
Agreement of two-dimensional and three-dimensional transvaginal ultrasound with magnetic resonance imaging in assessment of parametrial infiltration in cervical cancer
V. Chiappa, A. Di Legge, A.L. Valentini, B. Gui, M. Micco, M. Ludovisi, C. Giansiracusa, A.C. Testa and L. Valentin
Volume 45, Issue 4, pages 459–469, April 2015
http://onlinelibrary.wiley.com/doi/10.1002/uog.14637/abstract
Placental Elastography in Intrauterine Growth Restriction: A Case–control Studyasclepiuspdfs
Background: Intrauterine growth restriction (IUGR) is related to poor fetal outcome. Though, various tools are available for evaluation of IUGR they are notreliable inearly diagnosis of IUGR. Shear wave elastography (SWE) can be used to study the change in mechanical properties of various disease which can be a potential technique for early diagnosis of IUGR. Objective: The objective of the study was to compare the differences in SWE values of placentas between IUGR and normal pregnancies. Methodology: Normal second- and third-trimester pregnancies and IUGR pregnancies between 24 and 42 weeks period of gestation (POG), meeting the inclusion criteria were matched for age group and POG. SWE of placenta was performed in supine position during quiet respiration. The SWE of placenta was measured by placing the region of interest in relatively homogeneous area. The placental elasticity values obtained in pregnancies complicated by IUGR were compared with that of normal controls. Umbilical artery (UA) and fetal middle cerebral artery (MCA) Doppler findings were correlated with placental elasticity value of IUGR pregnancies.
Journees Liban 28/3/2017, Paris, France
Presentation in French Language about Higher education system in Lebanon: History, Statistics, Structure, Councils & committees, International relations, etc.
Wat zijn de mogelijkheden en handelingsperspectieven voor gemeenten om de kwaliteit van het ingezamelde en gesorteerde huishoudelijk kunststof verpakkingsafval te verbeteren?
Кто может рассказать о построении безупречной команды лучше, чем основатель организации и специалист по подбору персонала?
CEO компании Соціальний консалтинг "Параграф" Татьяна Гончаренко и HR-менеджер Anastasiia Reva раскроют секреты формирования ‘dream team’:
- как за год компания может вырасти из 4 сотрудников до 16 профессионалов, в деятельности которых есть своя зона ответственности;
- как уникальный опыт в бизнесе и общественной сфере формирует комплексный подход к работе с персоналом;
- как помочь сотруднику определить его роль в команде.
Transform your living space into beauty.Trent Altman
This slideshare highlights interior living spaces inspired by the abstract paintings of visual artist, Trent Altman, an accomplished award winning artist.
5 Insights to Master the Work Ahead in ManufacturingCognizant
Whether you’re a producer of consumer durables or industrial goods, the future of manufacturing isn’t just about using new technologies to design and make physical products. It’s about leveraging the power of digital to create more connected and personalized experiences for customers. Our latest study shows the way forward to the future of work for manufacturers. http://cogniz.at/TWAmfg
Neonatal and Obstetric Risk Assessment (NORA) Pregnancy Cohort Study in Singa...Premier Publishers
The Neonatal and Obstetric Risk Assessment (NORA) pregnancy cohort study was set up to assess clinical, biochemical and biophysical markers for risk assessment and prediction of the outcomes early in pregnancy. A total of 3271 patients who were in KK Women’s and Children’s Hospital between September 2010 and October 2014 were screened and 1013 patients consented to participate in the study. Women were followed at 18 to 22 weeks, 28 to 32 weeks and 34 weeks and above, till their postnatal discharge from the hospital. Finally, 926 patients remained for studying the outcome. In NORA study, we established locally derived and gestational age-specific reference intervals for the five thyroid hormone parameters. Higher serum progesterone levels at 28–32 weeks of pregnancy were observed in women who had preterm deliveries compared with women with term deliveries in the cohort. We also found that extracellular vesicle (EV) biomarkers enhanced the predictive robustness of an existing pre-eclampsia (PE) biomarker sufficiently to justify PE screening in a low-risk general obstetric population. We plan to further conduct a range of serial assessments from the biosamples which will provide a comprehensive and valuable information of the dynamics of maternal conditions and fetal development during pregnancy.
— This study was conducted to find out if AFI ≤ 5 cms has any clinical significance in identifying the subsequent fetal distress & associated maternal & perinatal outcomes, in pregnancies beyond 37 weeks. Methodology: This is a prospective case control study done from July 2010 to July 2012 (24 months) at Dr Vasantrao Pawar Medical College, Hospital and Research Center. Adgaon, Nashik. It study the pregnancy outcome comparison of 58 Anenatal Cases(ANCs)as Study Group with diangosis of oligohydramnios (AFI ≤ 5 cms) by ultrasound after 37 completed weeks of gestation w e r e compared with 58 ANCs (Control Group) with no oligohydramnios (AFI > 5 cms). These two groups were matched for other variables like age, parity, gestational age and any pregnancy complication. Results: There was significant difference between two groups. Hypertension and Preeclampsia were found significantly more in ANCs with oligohydramnios. FHR deceleration was also significantly higher in women with oligohydramnios. Women require LSCS were also significantly more in women with oligohydramnios. Newborn borned by women with oligohydramnios had significantly more chances to admit in NICU than in newborn born by women without oligohydramnios. Conclusion: It can be concluded from this study that women with oligohydramnios poor pregancy outcomes. Determination of AFI can be used as an adjunct to other fetal surveillance methods. Determination of AFI can be used as valuable screening test for predicting fetal distress in labour, requiring caesarean section.
Practice Bulletin #226, Screening for Chromosomal AbnormalitiesVõ Tá Sơn
Practice Bulletin #226, Screening for Chromosomal Abnormalities,
Hướng dẫn sàng lọc các bất thường nhiễm sắc thể
ACOG & SMFM 2020
Bs Võ Tá Sơn
0978846100 zalo
Professor Soo Downe presenting at the Doctoral Midwifery Research Society Alcohol & Medication in Pregnancy Conferene about 'Which horse for which courses? The EBM Problem in studies of pharmacological substances in maternity care'.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
1. Società Italiana di Ecografia Ostetrica e Ginecologica e Metodologie Biofisiche
Dott.ssa Silvia Visentin
2. BACKGROUND
Many nulliparous women undergo emergency obstetric procedures during labor, including operative vaginal
delivery and cesarean delivery (CD) 1,2.
However, we lack a reliable strategy for predicting which women will experience the greatest
difficulties during labor. This may be frustrating and disappointing for women and obstetricians alike. The
issue is important because CD in advanced labor has a higher morbidity (and mortality) than an elective pre-
labor CD.
If obstetricians and midwives could predict which women will need an operative delivery in their first labor,
increased risk might be avoided by offering an elective procedure to those at highest risk, while those at low
risk could be reassured and encouraged to pursue a vaginal delivery.
Although many risk factors for CD in nulliparous parturient have been identified, to date there has not been
an established method for determining the effects of multiple risk factors for determining the
probability of CD in an individual woman3.
The two principal indications for primary intrapartum CD in nulliparas are labor dystocia and abnormal fetal
heart rate patterns, neither of which can be accurately diagnosed until there has been a trial of labor.
Osterman MJ et al. National Vital Statistics Report. 2011;59(6).
Gibbons L et al. AJOG 2012;206(4):331 e331-319.
Patel RR et al. International Journal of Epidemiology. 2005;34(2):353-367.
3. The Genesis study had as objective to prospectively assess the use of
prenatally determined, maternal and fetal, anthropometric, clinical and
ultrasound features to develop a predictive tool for unplanned CD in
nulliparous women at term, before the onset of labor.
AIM OF THE STUDY
4. MATERIALS AND
METHODS
A prospective, multicenter, blinded observational study
conducted between October 2012 and June 2015
Seven Perinatal Ireland Research Consortium sites were
invited to partecipate.
The clinical activity of the seven participating sites
represents almost 80% of deliveries on the island of
Ireland.
The national cesarean delivery rate in Ireland was 28·2%
in 2013
An anticipated CD rate of 20% in the Robson group 1 and
2 participants (nulliparous patients with a singleton
pregnancy in a cephalic presentation, who had
spontaneous or induced labor respectively) was used.
Assuming a minimum 20% increase in risk for CD (i.e.
24%) for a one standard deviation increase in any
predictor, the estimated sample size was 2,268.
5. All nulliparous patients with a singleton, cephalic presentation from 39+0 to 40+6 weeks’ gestation with an uncomplicated
pregnancy at enrolment. All participants had a confirmed estimated date of delivery by either first trimester ultrasound or
a second trimester ultrasound which correlated with their menstrual dates
INCLUSION CRITERIA
ESCLUSION CRITERIA
Multiparas, multiple pregnancies, breech presentation, ruptured membranes (at time of study ultrasound) and pregnancy
complications such as pre-eclampsia, hypertension (requiring anti-hypertensive medication), fetal growth restriction,
obstetric cholestasis and gestational diabetes mellitus (GDM) requiring insulin or oral hypoglycemic agents at the time of
recruitment. GDM treated with diet alone was not an exclusion criterion. Women who had a clinically indicated obstetric
ultrasound performed after 34 weeks’ gestation for fetal biometry were also excluded from the study to obviate the
potential influence of late ultrasound-derived fetal size estimates on clinical decision-making regarding timing or mode of
delivery. Pre-existing medical conditions such as cardiac disorders, pre-gestational diabetes mellitus, seizure disorder or
bleeding disorders were also excluded.
6. Baseline characteristics were obtained such as:
Age, weight, height, BMI (all obtained at the first antenatal visit), Gestational
weight gain assessed at the study visit,
Screening for GDM and the screening method,
Maternal head circumference,
Ethnicity,
Attendance at prenatal classes, model of prenatal care,
Presence of written birth plan, medical history,
Previous history of cervical surgery,
Family history of CD in a first degree relative,
Marital status,
Smoking status, alcohol and drug use,
Employment details and highest level of education achieved.
DATA RECORDING
7. A study ultrasound examination was performed after 39 completed weeks and prior to 40 weeks
and 6 days.
Standard fetal biometry was measured including biparietal diameter (BPD), head circumference
(HC), abdominal circumference (AC), and femur length (FL), yielding a calculated estimated fetal
weight (EFW) using the Hadlock-4 formula.
The fetal head position and engagement were recorded at the time of the study ultrasound.
Biometric data from this ultrasound examination were not revealed to study participants.
Managing clinicians and midwives were also blinded to the results of fetal biometry, so as to avoid
any potential for bias from suspicion of fetal macrosomia influencing decisions relating to timing
and mode of delivery.
A biophysical score was performed and documented in the participants medical records.
PLANNING OF THE STUDY
8. Findings of an abnormal biophysical profile (<6/8)
A diagnosis of small for gestational age
An EFW >5,000 grams
were revealed to the study participants and managing clinicians, with all such revealed cases being excluded
from the study.
Standard perinatal and obstetric data were collected
Gestational age at delivery,
Onset of labor,
Use of prostaglandin for pre-induction cervical priming,
Amniotomy,
Use of oxytocin,
Maternal fever,
Type of analgesia used,
Duration of labor,
Mode of delivery,
Indication for operative delivery,
Perineal trauma and blood loss.
9. STATISTICAL ANALYSIS
The primary objective of the statistical analysis was to predict individual absolute risk of CD with optimal
calibration and discriminative ability.
Simple and multiple logistic regression analyses were used to model the maternal demographics and
ultrasound biometry risk factors for CD.
Continuous predictors were standardized using z-scores (predictor value – mean / standard deviation) to
show the relative effects of predictors.
The Akaike Information Criterion (AIC) was used to determine model fit.
The AIC is the asymptotically equivalent to leave-one out cross-validation (LOOCV) for penalizing
complexity. Validation analyses were performed on the full data (“apparent” model fit) in addition to re-
sampling methods: full boostrap sampling with replacement (1,000 repeats) and 10-fold cross-validation
(100 repeats).
SAS Version 9.2 was used for data management & data screening. SAS PROC LOGISTIC and
PROC NLMIXED were used for statistical modelling. Stata version 13 and the nomolog package
was used for the nomogram construction
10. RESULTS – Maternal Data
The average maternal age was 29 +/- 5·1 years
The average maternal BMI was 24·5 +/- 4·3 kg/m2.
Mean maternal gestational weight gain was 13·8 kg +/- 5·3 kg.
The majority were of European ethnicity (n=2,221, 95·2%).
77,4% attended prenatal education classes with 940 (40,3%).
The majority of the participants had never smoked (1,355, 58%), 774 (33·2%)
were ex- smokers and 206 (8·8%) were current smokers.
The highest level of education obtained in this cohort was third level (college or
university level) amongst 1,600 (68,6%) patients.
In this cohort 1,010 (4,2%) were formally tested for GDM.
12. RESULTS, MULTIVARIATE ANALYSIS
These parameters were used to develop a clinically useful
nomogram to predict an individualized patient risk assessment for
CD in nulliparous women at term.
The AUC was 0.69 and the misclassification rate was 21%
14. In the group with the highest predicted risk of CD
(predicted >50% probability of CD), which
represented 2.2% (n=52) of the cohort, 56% (n=29)
actually underwent a CD.
Only 13% (n=7) of women had an uncomplicated
vaginal delivery in this high risk cohort. In this cohort
28% (n=15) required an operative vaginal delivery,
9% (n=5) had an obstetric anal sphincter injury and
there was one case of a serious shoulder dystocia
with a fractured clavicle.
Using 50% as a high risk cut-off for CD the positive
likelihood ratio (LR) was 4.92 and the negative LR
was 0.95.
RESULTS
15. Five parameters (maternal age, BMI, height, fetal AC and fetal HC) can, in
combination, be used to better determine the overall risk of CD in nulliparous
women at term. A risk score can be used to inform women of their individualized
probability of CD. This risk tool may be useful for reassuring most women
regarding their likely success at achieving an uncomplicated vaginal delivery as well
as selecting those patients with such a high risk for CD that they should avoid a trial
of labor.
Such a risk tool has the potential to greatly improve planning hospital service needs
and minimizing patient risk.
CONCLUSIONS
16. The identification of women at high risk of CD (>50% risk) would also provide the
opportunity for informed decision making about the potential risks involved in
pursuing a vaginal delivery versus an elective CD. As maternal request for CD without
specific maternal or fetal indication becomes more common, this risk assessment tool
may prove useful in perinatal counselling to encourage those with a low risk of CD to
pursue a vaginal delivery.
CONCLUSIONS, Clinical Implications
17. The information provided in this manuscript contains all of the necessary
information for the model to be externally validated by other researchers in
different populations.
Further studies are necessary to assess the potential impact of this prediction
model.
Potential clinical impact studies should focus on using this risk assessment
tool for CD, to aid in decision making about timing and mode of delivery and
whether morbidity associated with prolonged labor or obstetric interventions
can be reduced.
CONCLUSIONS, Research Implications
18. CONCLUSIONS, Strengths
Prospective multi-center design
Blinding of clinicians to ultrasound-derived fetal biometry
Large sample size
Multiple risk factors assessed
Multiple time points from initial antenatal assessment (maternal age, BMI and height)
Late third trimester assessment to include fetal biometry.
Prediction model identified a small proportion with a very high risk (>50% or 1 in 2 chance) of CD, 2.2% (n=52)
CONCLUSIONS, Weaknesses
The average rate of induction for nulliparous patients in Ireland was 30% in 2009 but ranged from 18 to
47% nationally. In the cohort the rate of induction of labor was high at 40.5%.
Only 43% of the study population underwent a diagnostic test for gestational diabetes.